NEWS

 

Title Date
Oneness Biotech invited speaker at 2018 Asia Pacific Biotech Investment Forum hosted by Diamond Biofund Inc. 2018-11-12
Oneness Biotech receives license payment by Microbio (Shanghai) for obtaining the right of diabetic foot ulcer new drug, ON101 in China, Hong Kong and Macao. 2018-11-05
Oneness Biotech has been invited to present the clinical data of ON101 at the International Diabetes Federation, IDF) conference. 2018-10-22
Oneness Biotech invited to the 16th Annual Global Healthcare Conference by Morgan Stanley. 2018-09-05
Oneness Biotech submitted the plant-derived new drug application of ON101 (Diabetic foot ulcer drug) to TFDA 2018-05-14
US FDA approved the second Phase III clinical studies for the new drug from Oneness Biotech 2018-03-04